Marcus Capital’s Momenta Pharmaceuticals MNTA Stock Holding History
Bought
Maintained
Sold
Other funds holding MNTA
Marcus Capital's MNTA Position: Q4 2017 in Review
Marcus Capital sold out of Momenta Pharmaceuticals (MNTA) in Q4 2017, closing a stake of 50,400 shares — an estimated $932K sold.
Marcus Capital first reported a position in MNTA in Q1 2017 and held it in 3 quarters. The position peaked at $1.76M in Q2 2017. 166 funds tracked by Wall St. Rank hold MNTA as of Q4 2017.
- Marcus Capital reported no remaining Momenta Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
- Marcus Capital sold 50,400 Momenta Pharmaceuticals shares in Q4 2017, an estimated $932K.
- Marcus Capital first reported a position in Momenta Pharmaceuticals in Q1 2017 and held it in 3 quarters.
- Marcus Capital's Momenta Pharmaceuticals position peaked at $1.76M in Q2 2017.
- 166 funds tracked by Wall St. Rank held Momenta Pharmaceuticals as of Q4 2017.
Based on Marcus Capital's 13F filing for Q4 2017, filed 7 Feb 2018.